| http://www.w3.org/ns/prov#value | - pondents have argued that the disclosure in document (C1) did not enable the selection of the antibodies as recited in claim 1, i.e. the document did not technically elucidate the functions of BAFF, and did not disclose the BAFF-receptor and a method for the selection of the antibodies of claim 1, i.e. which are useful in the treatment of autoimmune diseases.11.
|
